Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $15.99, for a total transaction of $479,700.00. Following the sale, the president now directly owns 2,417,700 shares in the company, valued at $38,659,023. The trade was a 1.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Trading Up 1.9 %

NASDAQ:ALHC opened at $16.09 on Tuesday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $16.26. The company has a market cap of $3.09 billion, a PE ratio of -20.90 and a beta of 1.49. The company has a 50 day simple moving average of $14.48 and a two-hundred day simple moving average of $12.51.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Stifel Nicolaus increased their target price on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Barclays increased their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. Piper Sandler increased their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. Finally, Stephens reaffirmed an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research note on Monday, February 24th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Large investors have recently added to or reduced their stakes in the stock. R Squared Ltd bought a new stake in Alignment Healthcare in the 4th quarter worth approximately $55,000. RiverPark Advisors LLC bought a new position in Alignment Healthcare in the 4th quarter worth $106,000. Tower Research Capital LLC TRC boosted its holdings in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after buying an additional 6,286 shares during the period. Ballentine Partners LLC bought a new position in Alignment Healthcare in the 4th quarter worth $121,000. Finally, Aigen Investment Management LP purchased a new stake in Alignment Healthcare in the 4th quarter worth $129,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.